THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 85 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q4 2013. The put-call ratio across all filers is 1.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $30,000 | -28.6% | 77,385 | +5.8% | 0.00% | – |
Q1 2017 | $42,000 | +44.8% | 73,137 | +10.6% | 0.00% | – |
Q4 2016 | $29,000 | -40.8% | 66,140 | -7.4% | 0.00% | – |
Q3 2016 | $49,000 | -12.5% | 71,391 | -18.8% | 0.00% | – |
Q2 2016 | $56,000 | -52.9% | 87,965 | -66.0% | 0.00% | – |
Q1 2016 | $119,000 | -4.0% | 258,529 | -0.0% | 0.00% | – |
Q4 2015 | $124,000 | -88.2% | 258,639 | -0.0% | 0.00% | – |
Q3 2015 | $1,053,000 | -18.1% | 258,684 | -18.7% | 0.00% | – |
Q2 2015 | $1,286,000 | +4.2% | 318,282 | +4.7% | 0.00% | – |
Q1 2015 | $1,234,000 | +44.8% | 303,893 | +13.5% | 0.00% | – |
Q4 2014 | $852,000 | -12.3% | 267,851 | -0.5% | 0.00% | – |
Q3 2014 | $971,000 | -56.4% | 269,078 | -52.1% | 0.00% | – |
Q2 2014 | $2,226,000 | +68.4% | 562,096 | +102.3% | 0.00% | – |
Q1 2014 | $1,322,000 | +7.8% | 277,819 | +5.8% | 0.00% | – |
Q4 2013 | $1,226,000 | -50.0% | 262,630 | -50.1% | 0.00% | – |
Q3 2013 | $2,450,000 | +79.2% | 526,806 | +102.7% | 0.00% | – |
Q2 2013 | $1,367,000 | – | 259,909 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 625,558 | $2,540,000 | 1.95% |
CG Asset Management LLC | 128,000 | $520,000 | 0.20% |
Rotella Capital Management, Inc. | 45,364 | $184,000 | 0.15% |
TFS CAPITAL LLC | 348,617 | $1,415,000 | 0.14% |
Rhenman & Partners Asset Management AB | 201,537 | $818,000 | 0.14% |
FORTALEZA ASSET MANAGEMENT INC/ | 59,180 | $240,000 | 0.14% |
Baker Brothers Advisors | 2,925,519 | $11,878,000 | 0.10% |
FEDERATED HERMES, INC. | 3,918,305 | $15,908,000 | 0.05% |
FRANKLIN STREET ADVISORS INC /NC | 50,000 | $203,000 | 0.04% |
Princeton Alpha Management LP | 26,560 | $108,000 | 0.02% |